Wolfram Steinhilber

USPTO Granted Patents = 6 (Patent Applications = 2)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 6(Granted Patents)

Company Filing History:

3 out of 75

Amgen Research (munich) Gmbh

where one patent can have more than one assignee

Years Active: 2003-2020

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10758621 - Liquid formulation comprising GM-CSF neutralizing compound (2020-09-01),

2. 9919051 - Liquid formulation comprising GM-CSF neutralizing compound (2018-03-20),

3. 9833410 - Lyophilized formulation comprising GM-CSF neutralizing compound (2017-12-05),

4. 7135452 - Recombinant SP-A for the treatment or prevention of pulmonary infection and inflammation (2006-11-14),

5. 6737243 - Determination of the hydrophobic pulmonary surfactant protein SP-C (2004-05-18),

6. 6599752 - Process for separating and analyzing hydrophobic proteins using thin layer chromatography (2003-07-29),

Title: Wolfram Steinhilber: Innovator in Therapeutic Formulations

Introduction

Wolfram Steinhilber is a notable inventor based in Stockach, Germany. He has made significant contributions to the field of therapeutic formulations, particularly in the treatment of inflammatory and autoimmune disorders. With a total of six patents to his name, his work has had a considerable impact on medical science.

Latest Patents

One of his latest patents involves a liquid formulation comprising a GM-CSF neutralizing compound. This invention relates to aqueous formulations that include a compound neutralizing GM-CSF in concentrations of at least about 20 mg/ml, along with a tonicity modifier and a buffer. The composition is designed to be stable, ensuring the long-term storage of the compound. The formulation is intended for therapeutic use, particularly in treating inflammatory and autoimmune disorders, including allergic and psoriatic disorders, as well as arthritic and asthmatic conditions. Additionally, a kit containing this formulation is also provided.

Career Highlights

Wolfram Steinhilber has worked with prominent companies in the pharmaceutical industry, including Amgen Research (Munich) GmbH and Takeda GmbH. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Throughout his career, he has collaborated with notable colleagues such as Thomas Urbig and Thomas Boehm. These partnerships have likely enhanced his research and development efforts in the field.

Conclusion

Wolfram Steinhilber's contributions to the field of therapeutic formulations demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight his role as a significant inventor in the industry.

This text is generated by artificial intelligence and may not be accurate.